Indaptus Therapeutics, Inc. (INDP)
3.13
+0.13
(+4.33%)
USD |
NASDAQ |
Jan 09, 16:00
3.10
-0.03
(-0.96%)
After-Hours: 20:00
Indaptus Therapeutics Shareholders Equity (Quarterly): 4.606M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 534.14M |
| Citius Pharmaceuticals, Inc. | 67.55M |
| Applied Therapeutics, Inc. | -0.561M |
| Dermata Therapeutics, Inc. | 3.960M |
| CEL-SCI Corp. | 15.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.840M |
| Total Liabilities (Quarterly) | 2.234M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 2.882 |
| Net Debt Paydown Yield | 1.49% |